Article
The cyclooxygenase-2-765C promoter polymorphism protects against the development of chronic obstructive pulmonary disease.
Department of Pharmacology & Clinical Pharmacology, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand.
Respiratory medicine (impact factor:
2.33).
03/2011;
105(3):506-10.
DOI:10.1016/j.rmed.2010.08.002
pp.506-10
Source: PubMed
-
Citations (0)
-
Cited In (0)
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
-765 cyclooxygenase-2 polymorphism
171 chronic smokers
95 healthy blood donors
blood donors
Chronic Obstructive Pulmonary Disease
common
COPD
cyclooxygenase-2 gene
cyclooxygenase-2 gene influences
decreased activity
gene encoding
genetic component
genetic variant
polymerase chain reaction
promoter activity
resistant smokers
restriction enzyme fragment length polymorphism
smokers